Ultra-high density peptide arrays demonstrate unique patient-specific IgE and IgG4 epitope patterns for peanut allergens that persist over multiple years

A. Christiansen, Christian Skjødt Hansen, T. Eiwegger, E. Sullivan, J. Patel, Jens Vindahl Kringelum, Ole Lund, Z. Szepfalusi, Katrine Lindholm Bøgh, Martin Dufva

Research output: Contribution to journalConference abstract in journalResearchpeer-review

1 Downloads (Pure)

Abstract

Clinicians are seeing a growing number of cashew nut allergic patients. One of the peculiarities of this allergy is that a minimal amount of cashew nut allergen may cause severe allergic reactions, suggesting high potency of the allergen comparable to other tree nuts and peanuts.The double blind placebo controlled food challenge (DBPCFC) test is currently the gold standard to establish cashew nut allergy. The development of predictive tools in diagnosing cashew nut allergy is needed and research should be done on cross-sensitization between cashew nut and other botanically related allergens.
Original languageEnglish
Article number183
JournalAllergy
Volume70
Issue numberSuppl. 101
Pages (from-to)90-90
Number of pages1
ISSN0105-4538
DOIs
Publication statusPublished - 2015
EventEuropean Academy of Allergy and Clinical Immunology Congress 2015 - Barcelona, Spain
Duration: 6 Jun 201510 Jun 2015
https://eaaci.org/documents/congress/2021/150519%20BAJA%20Final_Programme_Barcelona_2015.pdf

Conference

ConferenceEuropean Academy of Allergy and Clinical Immunology Congress 2015
Country/TerritorySpain
CityBarcelona
Period06/06/201510/06/2015
Internet address

Fingerprint

Dive into the research topics of 'Ultra-high density peptide arrays demonstrate unique patient-specific IgE and IgG4 epitope patterns for peanut allergens that persist over multiple years'. Together they form a unique fingerprint.

Cite this